Since 2000, SCOPE has been your independent full-service CRO. We have 12 offices across Europe and a trusted global partner network. We deliver end-to-end clinical development and consulting services. This includes strategic planning, clinical phases I–IV, safety management, data management, and regulatory affairs. We have conducted over 300 studies in 30 countries and enrolled over 86,000 patients. SCOPE combines proven expertise with the agility to meet your trial objectives efficiently. As a mid-size CRO, we offer: – Direct access to senior experts for faster decisions – Tailored patient recruitment and engagement strategies, powered by our in-house marketing team – Efficient processes that keep timelines and costs on track – Close collaboration without the bureaucracy of large organizations Partnering with SCOPE means working with a CRO that is big enough to deliver but agile enough to adapt quickly. Our dedicated marketing team ensures your trial reaches the right patients faster. We guide your study smoothly from planning to completion.
Looking for a particular SCOPE International employee's phone or email?
The SCOPE International annual revenue was $8.1 million in 2026.
Michael Binder is the Director Operations of SCOPE International.
167 people are employed at SCOPE International.
SCOPE International is based in Mannheim, Baden-Württemberg.
The NAICS codes for SCOPE International are [5417, 54, 54171, 541710, 6215, 62, 541, 62151, 621].
The SIC codes for SCOPE International are [80, 8071, 807].